Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact
Clinical trial NCT05376527 · COMPLETED
Trial details
- NCT number
- NCT05376527
- Sponsor
- "Oncostar" LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-11
- Primary completion
- 2025-02-27
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.